Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Prostate-specific antigen evolution after photoselective vaporization of the prostate.

Lebdai S, Prezelin Y, Pereira H, Bruyere F.

J Endourol. 2014 Mar;28(3):347-52. doi: 10.1089/end.2013.0522. Epub 2013 Dec 3.

PMID:
24156628
3.

Postoperative Lower Urinary Tract Storage Symptoms: Does Prostate Enucleation Differ from Prostate Vaporization for Treatment of Symptomatic Benign Prostatic Hyperplasia?

Elkoushy MA, Elshal AM, Elhilali MM.

J Endourol. 2015 Oct;29(10):1159-65. doi: 10.1089/end.2015.0202. Epub 2015 Jun 18.

PMID:
25905430
4.

Holmium laser ablation of the prostate versus photoselective vaporization of prostate 60 cc or less: short-term results of a prospective randomized trial.

Elzayat EA, Al-Mandil MS, Khalaf I, Elhilali MM.

J Urol. 2009 Jul;182(1):133-8. doi: 10.1016/j.juro.2009.02.117. Epub 2009 May 17.

PMID:
19447438
6.

Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate.

Volkan T, Ihsan TA, Yilmaz O, Emin O, Selcuk S, Koray K, Bedi O.

Eur Urol. 2005 Oct;48(4):608-13.

PMID:
16135396
7.

Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection?

Tinmouth WW, Habib E, Kim SC, Kuo RL, Paterson RF, Terry CL, Elhilali M, Lingeman JE.

J Endourol. 2005 Jun;19(5):550-4.

PMID:
15989443
8.

Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.

Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M.

J Urol. 2000 Apr;163(4):1144-8; discussion 1148-9.

PMID:
10737484
9.

Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: prognostic implications.

Kavadi VS, Zagars GK, Pollack A.

Int J Radiat Oncol Biol Phys. 1994 Sep 30;30(2):279-87.

PMID:
7523340
10.

The role of PCA3 testing in patients with a raised prostate-specific antigen level after Greenlight photoselective vaporization of the prostate.

Henderson J, Ghani KR, Cook J, Fahey M, Schalken J, Thilagarajah R.

J Endourol. 2010 Nov;24(11):1821-4. doi: 10.1089/end.2010.0196. Epub 2010 Oct 21.

PMID:
20964483
11.

Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial.

Pollack A, Zagars GK, Antolak JA, Kuban DA, Rosen II.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):677-85.

PMID:
12377318
12.

Prostate-specific antigen spikes after permanent prostate brachytherapy.

Merrick GS, Butler WM, Wallner KE, Galbreath RW, Anderson RL.

Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):450-6.

PMID:
12243821
13.

Photoselective KTP laser vaporization of the prostate: first experiences with 65 procedures.

Sulser T, Reich O, Wyler S, Ruszat R, Casella R, Hofstetter A, Bachmann A.

J Endourol. 2004 Dec;18(10):976-81.

PMID:
15801365
14.

Prognostic significance of the nadir prostate specific antigen level after hormone therapy for prostate cancer.

Kwak C, Jeong SJ, Park MS, Lee E, Lee SE.

J Urol. 2002 Sep;168(3):995-1000.

PMID:
12187207
15.

Prostate specific antigen levels following transurethral resection of the prostate.

Fonseca RC, Gomes CM, Meireles EB, Freire GC, Srougi M.

Int Braz J Urol. 2008 Jan-Feb;34(1):41-8.

16.

PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases.

Aksoy Y, Oral A, Aksoy H, Demirel A, Akcay F.

Ann Clin Lab Sci. 2003 Summer;33(3):320-3.

PMID:
12956448
17.
18.
19.
20.

Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients.

Sarica K, Alkan E, Lüleci H, Taşci AI.

J Endourol. 2005 Dec;19(10):1199-202.

PMID:
16359215

Supplemental Content

Support Center